Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.06.2017 | original report

Clinicopathological profile and treatment outcome of squamous cell carcinoma breast at a tertiary cancer center in South India

verfasst von: Dr. A. H. Rudresha, MD, DM, Dr. Abhishek Anand, MD, Dr. K. C. Lakshmaiah, MD, DM, Dr. K. Govind Babu, MD, DM, Dr. D. Lokanatha, MD, DM, Dr. Amirtham Usha, MD, Dr. Linu Abraham Jacob, MD, DM, Dr. Suresh Babu, M.C. MD, DM, Dr. K. N. Lokesh, MD, DM, Dr. L. K. Rajeev, MD, DM, Dr. Deepak Koppaka, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Summary

Background

Squamous cell carcinoma of the breast (SCCB) is a rare entity with limited data pertaining to the clinicopathological profile and treatment outcome. These tumors are characterized by rapid progression and have a poor outcome. The optimal therapy for SCCB has not yet been standardized. Most patients with SCCB are treated with the similar conventional chemotherapy regimens used in the ductal variant of breast cancer.

Methods

This was an observational study of patients diagnosed with SCCB diagnosed from March 2013 to February 2015 at our institute. The medical records were reviewed and patients were contacted by telephone to study the clinicopathological profile and treatment outcome.

Results

We identified 5 (0.45%) patients of SCCB out of 1100 breast cancer patients treated in the department of medical oncology during this period. The median age at presentation was 48 years. All tumor specimens showed macroscopic findings of a cystic lesion and central necrosis. After a median follow-up of 32 months, 3 patients (60%) were alive, whereas 2 (40%) patients succumbed to disease progression after recurrence.

Conclusion

SCCB is a rare subtype of breast cancer with no standard treatment approach. These are associated with poor prognosis and larger studies are needed to investigate different treatment options.
Vorheriger Artikel The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling
Literatur
1.
Rosen PR. Chapter 19: squamous carcinoma. In: Rosen’s breast pathology, 2nd edn. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 455–61. 1st ed. 1997.
2.
Behranwala KA, Nasiri N, Abdullah N, et al. Squamous cell carcinoma of the breast: Clinicopathologicimplications and outcome. Eur J Surg Oncol. 2003;29:386–9.CrossRefPubMed
3.
Tayeb K, Saadi I, Kharmash M, et al. Primary squamous cell carcinoma of the breast: report of three cases. Cancer Radiother. 2002;6:366–8, in French.CrossRefPubMed
4.
5.
Hachiya H, Ishida T, Kurosumi M, Yokoe T, Ogawa T, Iino Y. Aclinicopathological study of 7 primary squamous cell carcinomaof breast. Jpn J Breast Cancer. 1988;3(4):565–9, in Japanese.
6.
Menes T, Schachter J, Morgenstern S, et al. Primary squamous cell carcinoma (SqCC) of the breast. Am J Clin Oncol. 2003;26:571–3.CrossRefPubMed
7.
Moisidis E, Ahmed S, Carmalt H, et al. Primary squamous cell carcinoma of the breast. ANZ J Surg. 2002;72:65–7.CrossRefPubMed
8.
Cardoso F, Leal C, Meira A, et al. Squamouscell carcinoma of the breast. Breast. 2000;9:315–9.CrossRefPubMed
9.
Lafreniere R, Moskowitz LB, Ketcham AS. Pure squamous cell carcinoma of the breast. J Surg Oncol. 1986;31:113–9.CrossRefPubMed
10.
Cornog JL, Mobini J, Steiger E, et al. Squamous carcinoma of the breast. Am J Clin Pathol. 1971;55:410–7.CrossRefPubMed
11.
The Japanese Breast Cancer Society. General rules for clinical andpathological recording of breast cancer, 15th ed. Tokyo: Kanehara; 2004.
12.
Troell A. Zwei Fälle von Plattenepithelcarcinom. Nord Med Ark. 1908;1:1–11.
13.
Sakurai K, Okamura H, Enomoto K, Nezu K, Wakabayashi K, Miyake H, et al. Two cases of primary pure squamous cell carcinoma of the breast. J Nihon Univ Med Assoc. 2003;62(12):673–6.
14.
Eggers JW, Chesney T. Squamous cell carcinoma of the breast: aclinicopathologic analysis of eight cases and review of literature. Hum Pathol. 1984;15:526–31.CrossRefPubMed
15.
Stevenson JT, Graham DJ, Khiyami A, Mansour EG. Squamous cell carcinoma of the breast: A clinical approach. Ann Surg Oncol 1996;3:367–74.
16.
Farrand R, Lavigne R, Lokich J, et al. Epidermoid carcinoma of the Breast. J Surg Oncol. 1979;12:207–12.CrossRefPubMed
17.
Weigel RJ, Ikeda DM, Nowels KW. Primarysquamous cell carcinoma of the breast. South Med J. 1996;89:511–5.CrossRefPubMed
18.
Sheen-Chen S, Chen Y, et al. Primarysquamous cell carcinoma of the breast. South Med J. 1992;85:207–9.CrossRefPubMed
19.
Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, et al. Squamous cell carcinoma of the breast. J Clin Oncol. 2005;23(31):7827–35.CrossRefPubMed
20.
Farrand R, Lavigne R, Lokich J. Epidermoid carcinoma of the breast. J Surg Oncol. 1979;12:207–11.CrossRefPubMed
21.
WHO. WHO classification of tumours of the breast. Metaplastic carcinoma, 4th ed. Lyon: IARC Press; 2012, pp 48–9.
22.
Kurumiya Y, Terasaki M, Okamoto Y, Gotoh Y, Asaba Y, Niimiya Y, et al. Squamous cell carcinoma of the breast, a study of 145cases in the domestic literature with 4 cases of our hospital. Surgery. 2003;65(9):1088–92, in Japanese.
23.
Zhang X, Zhang B, Zang F, Zhao L, Yuan Z, Wang P. Clinical features and treatment of squamous cell carcinoma of the breast. Onco Targets Ther. 2016;9:3181–5.CrossRefPubMedPubMedCentral
24.
Brack K, Ramaekers PC, Tjalma WA. Primary squamous cell carcinoma of the breast. Eur J Gynaecol Oncol. 2003;24(5):384–6.PubMed
25.
Hiramatsu K, Kato K, Hirata A, Matsuba H, Hara T, Ito T, et al. A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases. Jpn J Cancer Chemother. 2007;34(3):443–6.
26.
Kaise H, Sakamoto G, Akiyama F, Kasumi F, Yoshimoto M. A clinicopathological study of 22 primary squamous cell carcinomas of the breast. Jpn J Breast Cancer. 2000;15(2):178–82.
27.
Shigekawa T, Tsuda H, Sato K, Ueda S, Asakawa H, Shigenaga R, et al. Squamous cell carcinoma of the breast in the form of an intracystictumor. Breast Cancer. 2007;14(1):109–12.CrossRefPubMed
28.
Rostock RA, Bauer TW, Eggleston JC. Primary squamous carcinoma of the breast: a review. Breast. 1984;10:27–31.
Metadaten
Titel
Clinicopathological profile and treatment outcome of squamous cell carcinoma breast at a tertiary cancer center in South India
verfasst von
Dr. A. H. Rudresha, MD, DM
Dr. Abhishek Anand, MD
Dr. K. C. Lakshmaiah, MD, DM
Dr. K. Govind Babu, MD, DM
Dr. D. Lokanatha, MD, DM
Dr. Amirtham Usha, MD
Dr. Linu Abraham Jacob, MD, DM
Dr. Suresh Babu, M.C. MD, DM
Dr. K. N. Lokesh, MD, DM
Dr. L. K. Rajeev, MD, DM
Dr. Deepak Koppaka, MD
Publikationsdatum
01.06.2017
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2017
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-017-0335-3

Weitere Artikel der Ausgabe 4/2017

ASCO update: lung cancer

  • Open Access
  • short review

The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling

  • special report

ASCO-update: gastrointestinal tumors

  • Open Access
  • short review

Next generation sequencing: clinical applications in solid tumours

  • Open Access
  • short review

ASCO 2017—highlights of gynecological cancer

  • Open Access
  • short review

Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update

  • Open Access
  • short review